Anzeige
Mehr »
Login
Samstag, 20.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
13 Leser
Artikel bewerten:
(0)

Equities Updates on Top Gainers -- Research on Micron Technology, SINA, Mobile Telesystems, and Insmed

LONDON, April 21, 2014 /PRNewswire/ --

The US markets saw a mixed sentiment on Thursday, April 17, 2014, with the NASDAQ Composite closing at 4,095.52, up 0.23%, the Dow Jones Industrial Average ending the session at 16,408.54, down 0.10%, and the S&P 500 edging 0.14% higher to finish the trading session at 1,864.85. The session saw a positive impact from Energy, Industrials and Telecommunication Services sectors along with a drag from Information Technology, and Utilities sectors. A number of stocks saw large movements, including Micron Technology Inc. (NASDAQ: MU), SINA Corp. (NASDAQ: SINA), Mobile Telesystems OJSC (NYSE: MBT) and Insmed Inc. (NASDAQ: INSM). Free technical research on MU, SINA, MBT and INSM can be downloaded upon signing up at:

http://www.investor-edge.com/1415-register

Shares in Micron Technology Inc. edged 6.36% higher, finishing Thursday's session at $23.91. The stock fluctuated between $23.03 and $24.14 during the session with a trading volume of 46.21 million shares as compared with its three months average volume of 32.00 million shares. Shares in Micron Technology Inc. have gained 9.18% in the previous three trading sessions, 6.84% in the last three months, and 9.93% on YTD basis. The S&P 500 Information Technology Sector Index mapped a loss of 0.30% during the trading session and 1.97% in the last one month. The company's stock is trading above its 50-day and 200-day moving averages of $23.90 and $19.44, respectively. Furthermore, the company's stock is trading at a PE ratio of 12.58 and has a Relative Strength Index (RSI) of 55.71. Sign up today to read free research on MU at:

http://www.investor-edge.com/1415-MU-21Apr2014.pdf

On Thursday, SINA Corp.'s stock ended the session at $56.55, up 6.72%. A total of 12.72 million shares were traded, which is above with its three months average volume of 4.21 million shares. During the session, the stock traded between $52.48 and $58.20. SINA Corp.'s shares have advanced 7.86% in the past three trading sessions. However, the stock has declined 14.15% in the last one month and 32.88% on YTD basis. The S&P 500 Information Technology Sector Index mapped a loss of 0.30% during the trading session, while the same has gained 0.20% in the previous three months. The company's shares are trading below its 50-day and 200-day moving averages of $64.70 and $74.47, respectively. Further, the stock is trading at a PE ratio of 77.73 and has an RSI of 43.40. Sign up today to read free research on SINA at:

http://www.investor-edge.com/1415-SINA-21Apr2014.pdf

Shares in Mobile Telesystems OJSC finished Thursday's session at $17.10, up 8.57%. A total of 6.66 million shares were traded which was above its three months average volume of 3.86 million shares. The stock vacillated between $15.72 and $17.16 during the session. Shares of Mobile Telesystems OJSC have advanced 4.97% in the previous three trading sessions and 5.56% in the last one month, while the stock has fallen by 20.94% since the beginning of this year. The S&P 500 Telecommunication Services Sector Index mapped a gain of 0.37% during the trading session, and charted up 5.70% in the last one month. The company's shares are trading at a PE ratio of 15.90 and above its 50-day moving average of $16.90. Additionally, the company's stock has an RSI of 54.43. Sign up today to read free research on MBT at:

http://www.investor-edge.com/1415-MBT-21Apr2014.pdf

Insmed Inc.'s stock closed Thursday's session at $13.41, up 7.02%, after oscillating between $12.25 and $13.57. A total of 1.55 million shares were traded, which is above its three months average volume of 0.80 million shares. Insmed Inc.'s shares have lost 27.83% in the last one month and 21.12% on YTD basis. The S&P 500 Health Care Sector Index ended the session flat and has declined 4.41% in the last one month. The stock is trading below its 50-day and 200-day moving averages of $17.82 and $15.70, respectively. Moreover, the company's stock has an RSI of 32.77. Sign up today to read free research on INSM at:

http://www.investor-edge.com/1415-INSM-21Apr2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Investor-Edge

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.